Cargando…

Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation

Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly malignant neoplasms posing diagnostic challenge due to a lack of defining molecular markers. CNS neuroblastoma with forkhead box R2 (FOXR2) activation (CNS_NBL) emerged as a distinct pediatric brain tumor entity fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korshunov, Andrey, Okonechnikov, Konstantin, Schmitt-Hoffner, Felix, Ryzhova, Marina, Sahm, Felix, Stichel, Damian, Schrimpf, Daniel, Reuss, David E., Sievers, Philipp, Suwala, Abigail Kora, Kumirova, Ella, Zheludkova, Olga, Golanov, Andrey, Jones, David T. W., Pfister, Stefan M., Kool, Marcel, von Deimling, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860633/ https://www.ncbi.nlm.nih.gov/pubmed/33536079 http://dx.doi.org/10.1186/s40478-021-01118-5

Ejemplares similares

EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
por: Delaidelli, Alberto, et al.
Publicado: (2021)

PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
por: Delaidelli, Alberto, et al.
Publicado: (2022)

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
por: Capper, David, et al.
Publicado: (2018)

Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
por: Korshunov, Andrey, et al.
Publicado: (2022)

Rapid-CNS(2): rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study
por: Patel, Areeba, et al.
Publicado: (2022)

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes
por: Łastowska, Maria, et al.
Publicado: (2020)

Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
por: Tanem, Kristine Eidal, et al.
Publicado: (2022)

OTHR-41. Amplification of the PLAG family genes – PLAGL1 and PLAGL2 – is a key feature of a novel embryonal CNS tumor type
por: Keck, Michaela-Kristina, et al.
Publicado: (2022)

CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

ETMR-03. THE ROLE OF FOXR2 IN PEDIATRIC BRAIN CANCER
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2020)

IMG-05 Imaging characteristics of CNS NB-FOXR2 – a retrospective and MULTI-INSTITUTIONAL DESCRIPTION OF 25 CASES
por: Tietze, Anna, et al.
Publicado: (2022)

The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs)
por: Rogers, H A, et al.
Publicado: (2013)

PATH-26. RNA SEQUENCING OF FORMALIN-FIXED PARAFFIN-EMBEDDED SPECIMENS IN DIAGNOSTIC ROUTINE IDENTIFIES CLINICALLY RELEVANT GENE FUSIONS
por: Stichel, Damian, et al.
Publicado: (2020)

An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)
por: Rogers, H A, et al.
Publicado: (2009)

Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity
por: Schweizer, Leonille, et al.
Publicado: (2020)

ETMR-06. Molecular and clinical characteristics of CNS tumors withBCOR(L1) fusion/internal tandem duplication
por: Gojo, Johannes, et al.
Publicado: (2022)

LGG-33. ISOMORPHIC DIFFUSE GLIOMA HAS RECURRENT GENE FUSIONS OF MYBL1 OR MYB AND CAN BE DISTINGUISHED FROM OTHER MYB/MYBL1 ALTERED GLIOMAS BASED ON A DISTINCT MORPHOLOGY AND DNA METHYLATION PROFILE
por: Wefers, Annika K, et al.
Publicado: (2020)

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
por: Spence, Tara, et al.
Publicado: (2014)

Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up
por: Schepke, Elizabeth, et al.
Publicado: (2023)

FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2021)

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
por: Rahmanzade, Ramin, et al.
Publicado: (2023)

Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
por: Deng, Maximilian Y., et al.
Publicado: (2021)

PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

CNS and CNS diseases in relation to their immune system
por: Xu, Jianhao, et al.
Publicado: (2022)

Oligosarcomas, IDH-mutant are distinct and aggressive
por: Suwala, Abigail K., et al.
Publicado: (2021)

Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
por: Deng, Maximilian Y, et al.
Publicado: (2023)

Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
por: Suwala, Abigail K., et al.
Publicado: (2020)

Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model
por: Malchenko, Sergey, et al.
Publicado: (2017)

Flavonoids and the CNS
por: Jäger, Anna K., et al.
Publicado: (2011)

CNS Tuberculosis
por: Sheller, James R., et al.
Publicado: (1986)

Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma
por: Hielscher, Thomas, et al.
Publicado: (2022)

Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
por: Behling, Felix, et al.
Publicado: (2023)

PATH-11. PROSPECTIVE (EPI-)GENETIC CLASSIFICATION OF > 1,000 PEDIATRIC CNS TUMORS—THE MNP 2.0 STUDY
por: Sturm, Dominik, et al.
Publicado: (2020)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020)

Management of manifesting FOXRED1 carriers is complex
por: Finsterer, Josef, et al.
Publicado: (2019)

An optimized workflow to improve reliability of detection of KIAA1549:BRAF fusions from RNA sequencing data
por: Sommerkamp, Alexander C., et al.
Publicado: (2020)

Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells
por: Sabbagh, Mark F, et al.
Publicado: (2018)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Secondary CNS myeloma with remission after systemic CNS-penetrating agents
por: Fernandez, Luis G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17f3maqjs9orlmi2s3ecetasmk